FDA approves booster shots for high-risk patients and people 65 and over
The approval also applied to people who work in healthcare or who work in jobs that put them at high risk.
The Food and Drug Administration on Wednesday evening approved Pfizer-BioNTech coronavirus booster shots for people considered high-risk of severe illness and those 65 and older.
The approval also allows booster shots for people ages 18 to 64 who work in the healthcare field, or whose job puts them at high risk for serious complications for the virus.
According to Axios, this approval comes just days after the FDA’s advisory board overwhelmingly rejected booster shots for widespread use among the public.